Oxaliplatin pharmacokinetics and pharmacodynamics in adult cancer patients with impaired renal function

CH Takimoto, MA Graham, G Lockwood, CM Ng… - Clinical cancer …, 2007 - AACR
Purpose: To characterize the pharmacokinetics and pharmacodynamics of oxaliplatin in
cancer patients with impaired renal function. Experimental Design: Thirty-four patients were …
被引用次数：86 相关文章

Oxaliplatin pharmacokinetics and pharmacodynamics in adult cancer patients with impaired renal function

CH Takimoto, MA Graham, G Lockwood… - Clinical Cancer …, 2007 - experts.nebraska.edu
Purpose: To characterize the pharmacokinetics and pharmacodynamics of oxaliplatin in
cancer patients with impaired renal function. Experimental Design: Thirty-four patients were …
[PDF] researchgate.net

[PDF][PDF] Oxaliplatin Pharmacokinetics and Pharmacodynamics in Adult Cancer Patients with Impaired Renal Function

D Greenslade, SC Remick, S Sharma, S Mani… - Clin Cancer …, 2007 - researchgate.net
Purpose: To characterize the pharmacokinetics and pharmacodynamics of oxaliplatin in
cancer patients with impaired renal function. Experimental Design: Thirty-four patients were …

Oxaliplatin Pharmacokinetics and Pharmacodynamics in Adult Cancer Patients with Impaired Renal Function

CH Takimoto, MA Graham, G Lockwood, CM Ng… - Clinical Cancer …, 2007 - cir.nii.ac.jp
抄録< jats: title> Abstract</jats: title>< jats: p> Purpose: To characterize the pharmacokinetics
and pharmacodynamics of oxaliplatin in cancer patients with impaired renal function.</jats …

Oxaliplatin pharmacokinetics and pharmacodynamics in adult cancer patients with impaired renal function.

CH Takimoto, MA Graham, G Lockwood… - … Cancer Research: an …, 2007 - europepmc.org
Oxaliplatin pharmacokinetics and pharmacodynamics in adult cancer patients with impaired
renal function. - Abstract - Europe PMC Sign in | Create an account https://orcid.org Europe …

[引用][C] Oxaliplatin pharmacokinetics and pharmacodynamics in adult cancer patients with impaired renal function

CH TAKIMOTO, MA GRAHAM… - Clinical cancer …, 2007 - pascal-francis.inist.fr
Oxaliplatin pharmacokinetics and pharmacodynamics in adult cancer patients with impaired
renal function CNRS Inist Pascal-Francis CNRS Pascal and Francis Bibliographic …

Oxaliplatin pharmacokinetics and pharmacodynamics in adult cancer patients with impaired renal function

CH Takimoto, MA Graham… - Clinical Cancer …, 2007 - einstein.elsevierpure.com
Purpose: To characterize the pharmacokinetics and pharmacodynamics of oxaliplatin in
cancer patients with impaired renal function. Experimental Design: Thirty-four patients were …

Oxaliplatin pharmacokinetics and pharmacodynamics in adult cancer patients with impaired renal function

CH Takimoto, MA Graham… - Clinical Cancer …, 2007 - mayoclinic.elsevierpure.com
Purpose: To characterize the pharmacokinetics and pharmacodynamics of oxaliplatin in
cancer patients with impaired renal function. Experimental Design: Thirty-four patients were …

Oxaliplatin pharmacokinetics and pharmacodynamics in adult cancer patients with impaired renal function

CH Takimoto, MA Graham… - … : an official journal …, 2007 - pubmed.ncbi.nlm.nih.gov
Purpose To characterize the pharmacokinetics and pharmacodynamics of oxaliplatin in
cancer patients with impaired renal function. Experimental design Thirty-four patients were …

[引用][C] Oxaliplatin pharmacokinetics and pharmacodynamics in adult cancer patients with impaired renal function

T CH - Clin Cancer Res, 2007 - cir.nii.ac.jp
Oxaliplatin pharmacokinetics and pharmacodynamics in adult cancer patients with impaired
renal function | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 …